These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 22027729)

  • 21. The PICCOLETO study and beyond.
    Cortese B
    EuroIntervention; 2011 May; 7 Suppl K():K53-6. PubMed ID: 22027728
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assimilating the current clinical data of fully bioabsorbable stents.
    Di Mario C; Borgia F
    EuroIntervention; 2009 Dec; 5 Suppl F():F103-8. PubMed ID: 22100669
    [No Abstract]   [Full Text] [Related]  

  • 23. First nine-month complete invasive assessment (angiography, IVUS, and OCT) of the novel NEVO sirolimus-eluting stent with biodegradable polymer.
    Abizaid A; Costa JR; Feres F
    Catheter Cardiovasc Interv; 2011 Jan; 77(1):49-51. PubMed ID: 20506126
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Too early to call.
    Waksman R
    Cardiovasc Revasc Med; 2012; 13(3):157-8. PubMed ID: 22652313
    [No Abstract]   [Full Text] [Related]  

  • 25. Vascular restoration therapy: the fourth revolution in interventional cardiology and the ultimate "rosy" prophecy.
    Wykrzykowska JJ; Onuma Y; Serruys PW
    EuroIntervention; 2009 Dec; 5 Suppl F():F7-8. PubMed ID: 22100680
    [No Abstract]   [Full Text] [Related]  

  • 26. Rotational atherectomy with drug-eluting stents: a necessary technique in the current era.
    Lozano I; Rondan J; Avanzas P
    Catheter Cardiovasc Interv; 2011 Jan; 77(1):160; author reply 161. PubMed ID: 21069801
    [No Abstract]   [Full Text] [Related]  

  • 27. More openness and a little less strut: two good ideas for stents and the people who implant them.
    Morrison DA
    Catheter Cardiovasc Interv; 2010 Nov; 76(5):652-3. PubMed ID: 20976746
    [No Abstract]   [Full Text] [Related]  

  • 28. Is there a need for dedicated bifurcation devices?
    Lefèvre T; Chevalier B; Louvard Y
    EuroIntervention; 2010 Dec; 6 Suppl J():J123-9. PubMed ID: 21930476
    [No Abstract]   [Full Text] [Related]  

  • 29. Treatment of drug-eluting stent restenosis: a sandwich may not be the best combo.
    Belardi J
    Catheter Cardiovasc Interv; 2008 Apr; 71(5):599. PubMed ID: 18360848
    [No Abstract]   [Full Text] [Related]  

  • 30. The STENTYS® self-apposing stent in bifurcation lesions.
    Ramcharitar S; Verheye S
    EuroIntervention; 2010 Dec; 6 Suppl J():J151-4. PubMed ID: 21930482
    [No Abstract]   [Full Text] [Related]  

  • 31. The Nile concept.
    Fajadet J
    EuroIntervention; 2010 Dec; 6 Suppl J():J135-8. PubMed ID: 21930478
    [No Abstract]   [Full Text] [Related]  

  • 32. Provisional side branch stenting for the treatment of bifurcation lesions.
    Lefèvre T; Darremont O; Albiero R
    EuroIntervention; 2010 Dec; 6 Suppl J():J65-71. PubMed ID: 21930493
    [No Abstract]   [Full Text] [Related]  

  • 33. Repeat in-stent restenosis of drug-eluting stents in a bifurcation treated successfully with kissing drug eluting balloons.
    Abergel E; Beyar R; Roguin A
    Cardiovasc Revasc Med; 2013; 14(2):106-8. PubMed ID: 23195308
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 3-Year Follow-Up of the Balloon Elution and Late Loss Optimization Study (BELLO).
    Latib A; Ruparelia N; Menozzi A; Castriota F; Micari A; Cremonesi A; De Felice F; Marchese A; Tespili M; Presbitero P; Sgueglia GA; Buffoli F; Tamburino C; Varbella F; Colombo A
    JACC Cardiovasc Interv; 2015 Jul; 8(8):1132-1134. PubMed ID: 26205451
    [No Abstract]   [Full Text] [Related]  

  • 35. Drug-coated balloon treatment of coronary artery disease: a position paper of the Italian Society of Interventional Cardiology.
    Cortese B; Berti S; Biondi-Zoccai G; Colombo A; Limbruno U; Bedogni F; Cremonesi A; Silva PL; Sgueglia GA;
    Catheter Cardiovasc Interv; 2014 Feb; 83(3):427-35. PubMed ID: 23934956
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DES editorial. Is there a survival benefit?
    Thomas DM
    Catheter Cardiovasc Interv; 2008 Apr; 71(5):644-5. PubMed ID: 18360857
    [No Abstract]   [Full Text] [Related]  

  • 37. It's not the dye, but the "die" in dialysis: which coronary revascularization strategy really is best?
    Butman SM
    Catheter Cardiovasc Interv; 2010 Dec; 76(7):949-50. PubMed ID: 21108371
    [No Abstract]   [Full Text] [Related]  

  • 38. One step forward and two steps back with drug-eluting-stents: from preventing restenosis to causing late thrombosis and nouveau atherosclerosis.
    Nakazawa G; Vorpahl M; Finn AV; Narula J; Virmani R
    JACC Cardiovasc Imaging; 2009 May; 2(5):625-8. PubMed ID: 19442951
    [No Abstract]   [Full Text] [Related]  

  • 39. Do we really understand pimecrolimus?
    Vorpahl M; Finn AV; Nakano M; Virmani R
    JACC Cardiovasc Interv; 2009 Oct; 2(10):1025-7. PubMed ID: 19850265
    [No Abstract]   [Full Text] [Related]  

  • 40. Drug-eluting stent implantation for the treatment of cardiac transplant vasculopathy: the jury is still out.
    Belardi JA
    Catheter Cardiovasc Interv; 2011 Jun; 77(7):970-1. PubMed ID: 21598349
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.